Going Against Traditional Practice: How EU Pharmaceutical Companies Can Implement Supply Chain First in a Highly Validated ERP Program

Executive Summary

Traditional ERP implementation methodologies in pharmaceutical companies typically prioritise Finance-first deployments. The rationale is understandable: Finance is perceived as the backbone of control, compliance, and reporting. However, this sequencing increasingly conflicts with the realities facing international pharmaceutical organisations operating under intense market pressure.

In particular, companies launching new medicinal products across international markets cannot afford delays in supply chain readiness, even if Finance transformation is not yet complete.

This article explores how EU-based pharmaceutical companies can successfully and compliantly implement supply chain functionality first, followed by Finance six months later—within a single, highly validated ERP program—while remaining fully aligned with the latest EU regulatory expectations.

1. The Traditional ERP Model in Pharma – And Its Limitations

1.1 Why Finance-First Became the Norm

Historically, ERP programs in pharma have followed a predictable pattern:

1. Finance and Controlling (FI/CO)

2. Procurement and Inventory

3. Manufacturing and Quality

4. Sales and Distribution

This sequencing was driven by:

• The need for early financial control

• Perceived regulatory risk of operational modules

• Legacy accounting structures

• Waterfall project governance models

While logical in stable environments, this approach assumes:

• Product portfolios are mature

• Market demand is predictable

• Launch timelines are flexible

These assumptions no longer hold.

1.2 The Reality for International Pharma Companies Today

Modern pharma organisations face:

• Parallel product launches across multiple regions

• Shortened regulatory-to-commercial timelines

• Complex cold-chain and serialization requirements

• Pressure to scale manufacturing and distribution rapidly

• Increased scrutiny on supply resilience

In this context, supply chain capability—not finance transformation—often becomes the critical path.

2. The Strategic Case for Supply Chain First

2.1 Product Launches as the Forcing Function

When introducing two new products to international markets, the organisation must ensure:

• Material master readiness

• Batch management and traceability

• Qualified suppliers

• Distribution lanes

• Inventory visibility

• Demand and supply planning

• Regulatory-compliant documentation

Without a robust ERP-enabled supply chain, launch risk increases exponentially.

2.2 What “Supply Chain First” Really Means

A supply-chain-first ERP phase typically includes:

• Materials Management (MM)

• Production Planning (PP)

• Quality Management (QM)

• Warehouse Management (WM / EWM)

• Supply Chain Planning (where applicable)

• Serialization and traceability

• Interfaces to external logistics providers

Finance is not excluded—it is deferred, deliberately and strategically.

3. Breaking the Myth: “You Can’t Go Live Without Finance”

3.1 The Compliance Myth

A common belief is that:

An ERP system cannot be validated or compliant without Finance fully implemented.

This is incorrect.

EU regulations do not mandate module sequencing. They require:

• Data integrity

• Process control

• Traceability

• Validation evidence

A phased ERP is acceptable if properly designed, validated, and governed.

3.2 What Regulators Actually Expect

Key regulatory references include:

• EU GMP Annex 11 – Computerised Systems

• EU GMP Chapter 4 – Documentation

• ICH Q10 – Pharmaceutical Quality System

• EMA Guidance on Data Integrity

• GAMP 5 (2nd Edition)

None of these require Finance to precede supply chain.

They require:

• Intended use definition

• Risk-based validation

• Controlled interfaces

• Clear data ownership

• Ongoing system oversight

4. Designing a Two-Phase ERP Program in a GxP Environment

4.1 Phase 1 – Supply Chain-Centric Scope

Phase 1 focuses on operational readiness:

Core objectives:

• Enable production and distribution of new products

• Ensure full batch traceability

• Maintain GMP compliance

• Support international logistics

Modules typically included:

• MM (Procurement, Inventory)

• PP (Manufacturing)

• QM (Inspections, Batch Release)

• WM/EWM (Warehousing)

• Basic Sales Logistics (if required)

4.2 Phase 2 – Finance and Controlling

Phase 2, delivered six months later, introduces:

• FI (General Ledger, AP/AR)

• CO (Product Costing, Profitability)

• Asset Accounting

• Financial Reporting

By this point:

• Operational processes are stabilised

• Transaction volumes are known

• Cost structures are better understood

Finance implementation becomes simpler and more accurate.

5. Validation Strategy for a Phased ERP Go-Live

5.1 Validation Is Program-Wide, Not Phase-Specific

A critical success factor is treating validation as:

One validated system with phased intended use—not two separate systems.

This requires:

• A single Validation Master Plan (VMP)

• Clearly defined intended use per phase

• Risk-based testing aligned to active functionality

5.2 IQ/OQ/PQ Across Phases

Installation Qualification (IQ):

• Covers the full ERP technical landscape upfront

Operational Qualification (OQ):

• Focuses on active supply chain processes in Phase 1

• Finance scenarios deferred but documented

Performance Qualification (PQ):

• Validates real-world execution of supply chain processes

• Finance PQ executed in Phase 2

This approach is fully aligned with GAMP 5 principles.

6. Managing Financial Compliance During Phase 1

6.1 How Finance Operates During the Interim Period

During the six-month gap:

• Legacy finance systems remain system of record

• Financial postings are handled outside ERP

• Controlled interfaces or manual reconciliations are used

• Clear SOPs define responsibilities

This is acceptable if:

• Data integrity is maintained

• Controls are documented

• Reconciliations are auditable

6.2 Audit Readiness

Auditors typically focus on:

• Data lineage

• Access controls

• Change management

• Reconciliation logic

They do not require finance modules to be live—only that financial data is controlled and traceable.

7. Data Integrity and ALCOA+ in a Supply Chain-First Model

Supply-chain-first implementations must ensure:

• Attributable: Clear user actions in production and quality

• Legible: Electronic batch records

• Contemporaneous: Real-time postings

• Original: ERP as system of record

• Accurate: Validated master data

ERP systems are particularly strong in enforcing these principles—often more so than legacy landscapes.

8. Governance and Change Control

8.1 Strong Program Governance Is Non-Negotiable

Key governance elements include:

• Executive steering committee

• Integrated Quality representation

• Change Control Board (CCB)

• Clear escalation paths

Phased programs fail not due to sequencing—but due to weak governance.

8.2 Change Control During Phase Transition

Transitioning from Phase 1 to Phase 2 requires:

• Controlled configuration changes

• Impact assessments

• Regression testing

• Updated validation documentation

This is standard GMP practice—not an exception.

9. Business Benefits of Supply Chain First

9.1 Faster Time to Market

• Products reach patients sooner

• Regulatory approvals can be operationalised immediately

• Market opportunities are not lost to system delays

9.2 Reduced Program Risk

• Smaller initial scope

• Faster stabilisation

• Earlier user adoption

• Clearer requirements for Finance

9.3 Better Financial Design

Ironically, delaying Finance often leads to:

• Cleaner chart of accounts

• More accurate product costing

• Fewer reworks

10. Common Risks and How to Mitigate Them

11. Why This Approach Is Increasingly Relevant in the EU

EU regulators increasingly recognise:

• Agile operating models

• Risk-based validation

• Digital maturity differences across companies

A supply-chain-first ERP is not a shortcut—it is a strategic sequencing decision.

Conclusion

Implementing supply chain functionality first—before Finance—goes against traditional ERP practice in pharmaceutical companies. Yet under the pressure of international product launches, it is often the most responsible, compliant, and commercially sound decision.

When executed with:

• Strong governance

• Robust validation

• Clear regulatory alignment

…it allows pharmaceutical companies to deliver business value without compromising compliance.

Key Insights & Recommendations

• EU regulations do not mandate Finance-first ERP implementations

• Supply chain readiness is often the true critical path for product launches

• A single validated system can support phased functionality

• Risk-based validation enables compliant agility

• Strong governance determines success—not module sequence

• Delaying Finance can improve, not weaken, financial design